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COMFORTneo scores were 10 (IQR 10–11) preoperatively 
and 11 (10–12) postoperatively. The pain scores were com-
parable with those of other patients admitted to the NICU in 
the same time period.  Conclusions: Continuous morphine of 
10 μg/kg/h preoperatively, with an increase to 15 μg/kg/h 
postoperatively, seems to constitute a good starting dose for 
further individualized pain management guided by pain 
scores.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Necrotizing enterocolitis (NEC) is a dreadful and ex-
tremely painful complication that is related to very high 
morbidity and mortality  [1, 2] . Research efforts so far 
have mainly focused on etiology, surgical and conserva-
tive treatment and prevention of the disease  [3] . It is also 
important, though, to protect hospitalized neonates from 
pain, not only for ethical reasons but in view of the pos-
sible negative short- and long-term consequences of un-
treated pain  [4, 5] . However, there is surprisingly little 
research into optimal pain management for NEC  [6, 7] . 
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 Abstract 
 Background: Necrotizing enterocolitis (NEC) is known as an 
extremely painful childhood condition.  Objectives: The ob-
jective of this study was to explore pain management around 
NEC-related surgery in our neonatal intensive care unit 
(NICU) from a chart review of prospectively collected data on 
60 operated NEC patients admitted between 2008 and 2013 
with a median (IQR) gestational age of 28.3 (25.5–31.6) 
weeks.  Methods: Pain medication data and pain scores (i.e. 
COMFORTneo and Numerical Rating Scale pain and distress 
scores) from 72 h before until 72 h after surgery were col-
lected.  Results: Preoperatively, 95% of the patients received 
morphine versus 100% postoperatively, with a median dos-
age of 10.0 (IQR 9.7–14.5) and 16.9 (IQR 10.1–20.0) μg/kg/h, 
respectively. Postoperatively, 28 patients (46.7%) received 
additional fentanyl intermittently and 14 (23.3%) received 
midazolam, which was part of palliative treatment for 6 pa-
tients (42.9%). In patients receiving pain medication, median 
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In contrast to other intestinal diseases, such as an isolated 
perforation or congenital atresia, NEC is much more 
painful, both pre- and postoperatively, on account of the 
ongoing inflammatory and ischemic processes in the in-
testines as well as the related peritonitis  [8, 9] . There is 
consensus among clinicians that NEC-related pain must 
be assessed and treated, but how this should be done is 
unclear and this is usually left to the discretion of the 
treatment team  [10–12] . To our knowledge, there are no 
guidelines for the assessment and management of NEC-
related pain.
 While the main focus of current research on neonatal 
pain assessment is on acute procedural pain, NEC-related 
pain requires an instrument validated for the assessment 
of prolonged pain  [13] . In our hospital, a modified ver-
sion of the COMFORT-behavior scale, the COMFORT-
neo scale, was designed and validated to assess prolonged 
pain in premature neonates  [14] . 
 Opioids seem the most appropriate for pain manage-
ment in NEC  [15] . For premature infants weighing
<1,000 g, 10 μg/kg/h of morphine or 0.5–2 μg/kg/h con-
tinuous fentanyl is considered a reasonable dosage to re-
lieve NEC-related pain  [16] , although there is no evi-
dence for this assumption. Based on the latest population 
pharmacokinetic/pharmacodynamic (PK/PD) model for 
morphine, lower postoperative dosages might be more 
appropriate in neonates undergoing major noncardiac 
surgery, particularly when they are <10 days of age  [17, 
18] , but the question remains whether this holds for NEC 
patients as well.
 This study describes pain management in neonates 
before and after NEC-related surgery according to the 
guidance of validated pain scales. We also aimed to de-
termine if their pain assessment scores were comparable 
to those of patients admitted to the NICU with other di-
agnoses.
 Materials and Methods 
 Study Design 
 This was a retrospective chart review of prospectively collected 
data in the computerized Patient Data Management System 
(PDMS).
 Patients and Setting 
 All neonates admitted to the level III neonatal intensive care 
unit (NICU) of the Erasmus University Medical Center – Sophia 
Children’s Hospital, Rotterdam, The Netherlands, who underwent 
a laparotomy for suspected or confirmed NEC (Bell stages 2 and 
3) from January 2008 to December 2013 were included. Patients 
with a focal intestinal perforation were excluded, as this was con-
sidered a separate entity  [19] . Because of the different histopathol-
ogy and possible differences regarding pain, our study concentrat-
ed on operated infants with confirmed NEC. 
 The pain management protocol is described in  figure 1 . Guided 
by pain scores, analgesics could be titrated. In case of suspected 
pain during caregiving, intermittent fentanyl could be added. 
There is a probable synergistic sedative effect between morphine 
and midazolam  [20] . Midazolam is therefore sometimes given to 
preterm neonates whose discomfort does not adequately respond 
to morphine therapy. This pain protocol is used for all NICU pa-
tients and not specifically for NEC patients.
 Data Collection 
 The following data were retrieved from the PDMS: sex, date of 
birth, gestational age at birth, date of surgery, medication data and 
pain and distress scores. The time of the start and end of surgery 
and confirmation of the NEC diagnosis were retrieved from sur-
gery reports. The time of the NEC diagnosis is often unclear. 
Therefore, a time-span of 72 h was chosen for specific data collec-
tion. Medication data and COMFORTneo and Numerical Rating 
Scale (NRS) pain and distress scores were collected for the period 
from 72 h before the start of surgery until 72 h after the end of sur-
gery, excluding intraoperative medication. For the patients who 
died within 72 h after surgery, the data collected until the time of 
death were included in the analysis. The type of surgery was cate-
gorized by a surgeon (C.M.G.K.-D.). 
 In addition, to enable comparison with other patients, the 
COMFORTneo and NRS pain scores for all other patients, both 
surgical and nonsurgical, who were admitted to the NICU in the 
research period, were also retrieved. The advised morphine dos-
ages according to the PK/PD model of Krekels et al.  [17] , based on 
the birth weight and postnatal age, were also calculated.
 Measurement Instruments  
 Nurses in our NICU are trained to apply the COMFORTneo 
scale, an NRS for pain and an NRS for distress. A nurse’s interrater 
reliability for the COMFORTneo scale was assessed from the 
weighted Cohen’s kappa  [21] , calculated from the results of 10 
paired assessments with a qualified nurse. The COMFORTneo 
score has been validated for the use in the NICU  [14] . The cut-off 
score for pain is set at  ≥ 14. The total score ranges from 6 to 30. 
NRS scores range from 0 to 10; cut-off scores for NRS pain and 
NRS distress are both set at  ≥ 4. The pain management protocol 
prescribes that each neonate is assessed while resting at least once 
during every 8-hour shift. Extra assessment is indicated after the 
administration of sedatives or analgesics and if pain or over-/un-
dersedation is suspected. 
 Data Analysis 
 Data were exported from the PDMS automatically to SPSS 
v21.0 (SPSS Inc., Chicago, Ill., USA). 
 Postoperative morphine dosages were compared with the re-
cently advised morphine dosage for postoperative neonates after 
major noncardiac surgery by Krekels et al.  [17] . Median COM-
FORTneo scores, NRS pain and NRS distress before and after sur-
gery were compared with the Wilcoxon signed-rank test. The in-
stitutional ethical review board waived the need for approval be-
cause the participants did not have to undergo medical procedures 
or follow special rules of behavior (MEC-2014-547).
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 Results 
 Patients 
 Figure 2 shows the patient flow diagram for this study. 
Of the 80 neonates operated on due to suspected or prov-
en NEC between 2008 and 2013, 60 were included in this 
study. Three patients were admitted to the Pediatric ICU 
and 1 patient had already undergone a laparotomy in an-
other NICU; these 4 were excluded because of possible 
differences in pain management. 
 Table 1 shows patients’ background characteristics. 
The median gestational age was 28 weeks and 3 days 
and median postnatal age at the time of surgery was 10 
days (range 5–57 days). Fourteen patients (23.3%) died 
Assess pain with
COMFORTneo and
NRS pain/distress
COMFORTneo 9–13 and
NRS pain/distress <4
Continue current
treatment
COMFORTneo 8 and
NRS pain/distress <4
Decrease pain
treatment stepwise
COMFORTneo 14 or
NRS pain/distress 4
during rest
COMFORTneo 14 or
NRS pain/distress 4
COMFORTneo 14 or
NRS pain/distress 4
COMFORTneo 14 or
NRS pain/distress 4
Start morphine
loading dose 100 μg/kg
continuous 10 μg/kg/h
Start midazolam 0.1 mg/kg/h
Increase stepwise
Maximum 0.25 mg/kg/h
Switch to
continuous fentanyl
Start intermittent fentanyl
Maximum 3 μg/kg
Maximum 6 times/day
Increase morphine
stepwise
Maximum 20 μg/kg/h
Consult pain consultant
Suggested pain
during caregiving
 Fig. 1. Pain treatment flow diagram. 
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within 72 h after surgery. All of these deaths were re-
lated to NEC and were preceded by the decision to with-
draw IC treatment; 10 of them had (almost) completely 
necrotic intestines and the other 4 had undergone a 
’second look’ operation to evaluate viability of the in-
testines within 72 h.
 Pain Assessment 
 The COMFORTneo and NRS pain and distress scores 
were available for 56 patients (93.3%) preoperatively and 
52 (86.7%) postoperatively. The patients without preop-
erative pain scores had been admitted 5–15 h before sur-
gery. The patients without pain scores postoperatively 
had died within 2–9 h after surgery. COMFORTneo 
scores 72 h after surgery were significantly higher than 
those 72 h before surgery (Wilcoxon signed-rank test,
p = 0.012). Median NRS pain was higher preoperatively 
than postoperatively, but the difference was not statisti-
cally significant (Wilcoxon signed-rank test, p = 0.117). 
Median NRS distress tended to be higher after surgery 
than before surgery but this was not statistically signifi-
cant (Wilcoxon signed-rank test, p = 0.099).
 Table 2 shows the pain scores of the NEC patients in 
the 72-hour preoperative and postoperative periods and 
of all other NICU patients admitted in the study period. 
These results are presented in  figure 3 as median COM-
FORTneo and NRS pain scores per patient. 
 Thirteen patients received only morphine (21.7%). 
One, two or three additional analgesic or sedative drugs 
were administered to 36 patients (60.0%), 10 patients 
(16.7%) and 1 patient (1.7%), respectively.
 Pain Management 
 All patients received morphine after surgery. Fifty-
seven of them (95%) also received morphine before sur-
gery ( table 2 ). The maximum and median doses per pa-
tient in μg/kg/h were both significantly higher after sur-
gery (both Wilcoxon signed-rank test, p < 0.001). After 
surgery, almost half of the patients (46.7%) were also giv-
en intermittent fentanyl before procedures that are pain-
Operated NEC patients
2008–2013
(n = 80)
Other abdominal
problems
(n = 16)
Focal intestinal
perforation
(n = 5)
Confirmed NEC
(n = 64)
Patient already
operated
(n = 1)
Admitted
to PICU
(n = 3)
Included
patients
(n = 60)
Stenosis as result
of previous NEC
(n = 6)
Other abdominal
problems
(n = 5)
 Fig. 2. Patient flow diagram. PICU = Pedi-
atric ICU. 
 Table 1.  Background characteristics of 60 patients
Variables
Boy/girl 24 (40)/36 (60)
Gestational age, weeks+days 28 + 3 (25 + 5 – 31 + 6)
Birth weight, g 1,053 (836 – 1,525)
Postnatal age at surgery, days 10 (8 – 22)
Death within 72 h after surgery 14 (23.3)
Relaparotomy within 72 h 4 (6.7)
Bell staginga
2B
3A
3B
5 (8.3)
17 (28.3)
38 (63.3)
Preoperative drain 3 (5.0)
Surgery
(Almost) complete necrotic intestines
Partial jejunal/ileal resection
Ileocecal resection/hemicolectomy/
partial colon resection
10 (16.7)
18 (30.0)
15 (11.7)
Subtotal colectomy
Partial jejunal/ileal and partial colon 
resection
Isolated creation of stoma/clip and drop
7 (11.7)
6 (10.0)
4 (6.7)
 Values are expressed as n (%) or median (IQR). 
a Adapted Bell’s criteria [23].
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ful for such patients, such as diaper change. Fourteen pa-
tients (23.3%) additionally received midazolam after sur-
gery; for 6 of them, this was part of the palliative treatment. 
Median doses are presented as median per patient.
 Figure 4 shows the relation between postoperative 
morphine dosages in our research population (except for 
in those who died within 72 h after surgery) and the mor-
phine dosages calculated according to the PK/PD model 
of Krekels et al.  [17] .  This validated model is based on 
term newborns that undergo major noncardiac surgery 
and receive a loading dose of 100 μg/kg in the operating 
room. Dosage recommendations are based on their post-
natal age (i.e.  ≤ 10 days or >10 days) and weight. It shows 
that all neonates in our research population required 
more morphine than the calculated dosages. 
 Discussion 
 We found that pain scores for neonates who under-
went surgery for NEC were acceptable and comparable to 
those of all other patients admitted to the NICU in the 
same period. Median continuous morphine dosages of 10 
and 17 μg/kg/h before and after surgery were needed, re-
 Table 2.  Pain assessment results for NEC patients and all other patients admitted to the NICU in 2008 – 2013 as well as a list of the an-
algesics and sedatives administered before and after surgery
72 h before surgery 72 h after surgery All other NICU patients
Patients assessed
Total number of COMFORTneo scores/patient
56 (93.3)
9 (5 – 12)
52 (86.7)
13 (11 – 16)
3,685
8 (3 – 22)
COMFORTneo
Score
Patients with at least one score ≥14
Patients with at least one score ≤8
10 (10 – 11)
27 (45.0)
33 (55.0)
11 (10 – 12)
37 (61.7)
33 (55.0)
10 (10 – 11)
1,760 (47.7)
1,659 (45.0)
NRS pain
Score
Patients with at least one score ≥4
0 (0 – 2)
31 (51.7)
0 (0 – 1)
23 (38.3)
0 (0 – 0)
516 (14.0)
NRS distress
Score
Patients with at least one score ≥4
0 (0 – 0)
11 (18.3)
0 (0 – 0)
17 (28.3)
0 (0 – 0)
1,193 (32.4)
Morphine
Patients
Cumulative dose, μg/kg/72 h
Dose, μg/kg/h
Maximum
Median
57 (95.0)
307 (133 – 626)
14.6 (10.0 – 19.8)
10.0 (9.7 – 14.5)
60 (100)
895 (459 – 1177)
19.8 (15.0 – 20.5)
16.9 (10.1 – 20.0)
–
Fentanyl
Patients on intermittent dosage
Patients on continuous dosage
Dose, μg/kg
Number of doses
21 (35.0)
–
2.0 (1.7 – 2.3)
1.0 (1.0 – 2.5)
28 (46.7)
2 (3.3)
2.0 (1.3 – 2.2)
4.0 (2.0 – 8.0)
–
Acetaminophen
Patients 1 (1.7) 5 (8.3) –
Midazolam
Patients
Cumulative dose, mg/kg/72 h
Used for palliative treatment
3 (5.0)
3.5 (0.5 – 3.6)
–
14 (23.3)
1.0 (0.4 – 1.8)
6 (42.9)
–
Clonidine
Patients – 1 (1.7) –
Values are expressed as n (%) or median (IQR).
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spectively, to reach adequate analgesia. One or more ad-
ditional analgesics, particularly fentanyl, were needed in 
88.3% of the patients. 
 To our knowledge, only one other paper has been pub-
lished on pain assessment and pharmacological manage-
ment in infants with NEC  [22] . This retrospective study 
included 25 infants with stage II NEC, and pain was as-
sessed with the PIPP (Premature Infant Pain Profile), 
which is validated for acute painful procedures only. 
Nurses’ compliance with pain assessment was poor and 
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 Fig. 3. Box plots showing COMFORTneo scores ( a ) and NRS pain scores ( b ) for the patients with NEC. ° = Any 
score > 1.5 × the IQR from the rest of the scores (mild outliers); * = any score > 3 × the IQR from the rest of the 
scores (extreme outliers). 
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the PIPP scores were not presented. The mean morphine 
infusion during 5 days after initial diagnosis was 15 μg/
kg/h combined with a mean dose of fentanyl of 3 μg/kg/h. 
The morphine doses that they used are comparable to 
ours and slightly higher than those suggested by Thiaga-
rajah and Thiagarajah  [16] , i.e. 10 μg/kg/h for premature 
infants weighing <1,000 g in the postoperative period af-
ter a laparotomy for NEC. 
 The recently advised morphine dose for postoperative 
neonates after major noncardiac surgery by Krekels et al. 
 [17]  is much lower than what our patients needed ( fig. 4 ). 
Even though they did not study preterm neonates weigh-
ing <2 kg, it seems that in NEC and NEC-related surgery, 
separate dosing guidelines are necessary for the adminis-
tration of morphine and additional analgesics. Postop-
eratively, neonates received significantly more morphine 
and also more additional analgesic or sedative drugs than 
preoperatively. Based on our study, we would advise 
starting at 10 μg/kg/h of morphine after a loading dose 
when NEC is diagnosed. Postoperatively, this dose should 
be increased to 15 μg/kg/h. Intermittent fentanyl can be 
added if pain assessment during caregiving indicates 
pain. If, subsequently, pain scores during rest remain too 
high, the morphine dosage should be increased to up to 
20 μg/kg/h. Continuous fentanyl and the addition of mid-
azolam are alternatives if this maximum dose is still inad-
equate to achieve sufficient comfort. Although not fre-
quently used in our study, intermittent intravenous 
paracetamol administration might be beneficial  [18] but 
needs further study in this specific population.
 Dosing of analgesics and sedatives needs to be adjusted 
on the guidance of pain scores to prevent oversedation 
and undersedation. The assessment of pain should always 
be made before and after changes in analgesic treatment 
with, for instance, the COMFORTneo scale or the EDIN 
(Échelle Douleur Inconfort Nouveau-Né)  [13, 14] , vali-
dated for prolonged pain. We showed that median COM-
FORTneo scores for patients with NEC were comparable 
to those of other NICU patients admitted in the same pe-
riod. Both before and after surgery, 55% of patients in our 
study population were assigned a COMFORTneo score 
of  ≤ 8 compared to 45% of the other patients. If overseda-
tion had been a problem in our study population, we 
would have expected the difference between the groups 
to have been larger. We do realize, however, that COM-
FORTneo scores of  ≤ 8 are acceptable in patients who do 
not receive opioids or sedatives but are simply in a deep 
sleep. Because of the possibility of unjustifiably low pain 
scores due to the lack of body movements and blank facial 
expression which are common in NEC patients [13], it is 
important that not only the COMFORTneo scores but 
also the NRS scores are acceptable  [13] .
 The findings of this study offer a first step towards ev-
idence-based guidelines. Because the management of 
pain in NEC patients is still neglected in the scientific lit-
erature, prospective studies are needed to validate pain 
management guidelines and an adequate pain assessment 
instrument. Further research is also needed on specific 
behavioral and physiological item changes related to pain 
in NEC patients and to search for biomarkers and spe-
cific stress responses. 
 One strength of this study is the relatively large cohort 
studied, which allowed for reliable insight into the pain 
management in these very ill patients. The study did, 
however, have a retrospective design and only described 
pain management in our NICU during the research pe-
riod. Furthermore, nonoperated NEC patients were not 
included, which limits the generalizability of our results.
 In conclusion, the pain management based on pain 
scores for patients with severe NEC in our NICU was ac-
ceptable. This assumption is strengthened by the finding 
that both preoperative and postoperative COMFORTneo 
25
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g/
kg
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)
20 25
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Received more than calculated
n = 46
<1 kg
1–2 kg
>2 kg
 Fig. 4. Calculated PK/PD model-based morphine maintenance 
doses for neonates after major noncardiac surgery as a follow-up 
to 100 μg/kg/h loading dose  [17] (x-axis) compared to the average 
received morphine doses in neonates after NEC surgery over 72 h 
(y-axis). Doses are provided for different groups of patients based 
on birth weight. 
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scores were comparable to those of all other patients ad-
mitted to the NICU in the same period. The morphine 
dosages needed were much higher than suggested for pe-
diatric noncardiac surgery in a recent PK/PD model. In 
patients with severe NEC, continuous morphine of 10 μg/
kg/h preoperatively and an increase to 15 μg/kg/h post-
operatively seem to constitute a good starting dose for 
further individualized pain management guided by pain 
scores. 
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